Hungarian company is looking for partners to pre-sell and distribute a therapeutic device developed for infants to treat childhood oral thrush from the end of 2025. The device has an international patent application and is unique in the world.
The biotechnology company based in Hungary, specializes in implantable phototherapy devices. Their innovative product, is a patented pacifier designed to treat infant oral thrush using a scientifically validated light-based method. The device offers a safe, effective, and drug-free alternative to traditional treatments. The company seeks commercial agreements for market entry and investment partnerships to support clinical trials, production scaling, and global distribution.